
Kevin E. Weddington
Examiner (ID: 6966)
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1614, 1205, 1629, 2899 |
| Total Applications | 3386 |
| Issued Applications | 2180 |
| Pending Applications | 434 |
| Abandoned Applications | 815 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8164870
[patent_doc_number] => 08173709
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-08
[patent_title] => 'Anti-infective methods for treating pathogen-induced disordered tissues'
[patent_app_type] => utility
[patent_app_number] => 10/816571
[patent_app_country] => US
[patent_app_date] => 2004-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 28374
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/173/08173709.pdf
[firstpage_image] =>[orig_patent_app_number] => 10816571
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/816571 | Anti-infective methods for treating pathogen-induced disordered tissues | Mar 31, 2004 | Issued |
Array
(
[id] => 7018849
[patent_doc_number] => 20050220868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Policosanol composition and its use in treatment of hypercholesterolemia'
[patent_app_type] => utility
[patent_app_number] => 10/813017
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1792
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20050220868.pdf
[firstpage_image] =>[orig_patent_app_number] => 10813017
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/813017 | Policosanol composition and its use in treatment of hypercholesterolemia | Mar 30, 2004 | Abandoned |
Array
(
[id] => 7466568
[patent_doc_number] => 20040198740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Therapies relating to combinations of aldose reductase inhibitors and cyclooxygenase-2'
[patent_app_type] => new
[patent_app_number] => 10/810880
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27918
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198740.pdf
[firstpage_image] =>[orig_patent_app_number] => 10810880
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/810880 | Therapies relating to combinations of aldose reductase inhibitors and cyclooxygenase-2 | Mar 24, 2004 | Abandoned |
Array
(
[id] => 4537198
[patent_doc_number] => 07875282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-25
[patent_title] => 'Coated medical device for local vascular delivery of Panzem® in combination with rapamycin to prevent restenosis following vascular injury'
[patent_app_type] => utility
[patent_app_number] => 10/805736
[patent_app_country] => US
[patent_app_date] => 2004-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 71
[patent_no_of_words] => 50326
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/875/07875282.pdf
[firstpage_image] =>[orig_patent_app_number] => 10805736
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/805736 | Coated medical device for local vascular delivery of Panzem® in combination with rapamycin to prevent restenosis following vascular injury | Mar 21, 2004 | Issued |
Array
(
[id] => 7410484
[patent_doc_number] => 20040176373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Novel method of treatment'
[patent_app_type] => new
[patent_app_number] => 10/803300
[patent_app_country] => US
[patent_app_date] => 2004-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3506
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176373.pdf
[firstpage_image] =>[orig_patent_app_number] => 10803300
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/803300 | Novel method of treatment | Mar 17, 2004 | Abandoned |
Array
(
[id] => 7250144
[patent_doc_number] => 20040258774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Method of using a compound of menthol and L-arginine as a preparation for the topical delivery of a 5-phosphodiaesterase inhibitor for the treatment of female sexual dysfunction'
[patent_app_type] => new
[patent_app_number] => 10/803148
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 777
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20040258774.pdf
[firstpage_image] =>[orig_patent_app_number] => 10803148
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/803148 | Method of using a compound of menthol and L-arginine as a preparation for the topical delivery of a 5-phosphodiaesterase inhibitor for the treatment of female sexual dysfunction | Mar 16, 2004 | Abandoned |
Array
(
[id] => 7411015
[patent_doc_number] => 20040176420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Treatment of diabetes with thiazolidinedione and sulphonylurea'
[patent_app_type] => new
[patent_app_number] => 10/800579
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3484
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176420.pdf
[firstpage_image] =>[orig_patent_app_number] => 10800579
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/800579 | Treatment of diabetes with thiazolidinedione and sulphonylurea | Mar 14, 2004 | Abandoned |
Array
(
[id] => 7265135
[patent_doc_number] => 20040242671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug'
[patent_app_type] => new
[patent_app_number] => 10/489660
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9468
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242671.pdf
[firstpage_image] =>[orig_patent_app_number] => 10489660
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/489660 | Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug | Mar 14, 2004 | Abandoned |
Array
(
[id] => 7468927
[patent_doc_number] => 20040167172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Combination therapy for type II diabetes or syndrome X'
[patent_app_type] => new
[patent_app_number] => 10/790444
[patent_app_country] => US
[patent_app_date] => 2004-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7088
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 671
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20040167172.pdf
[firstpage_image] =>[orig_patent_app_number] => 10790444
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/790444 | Combination therapy for type II diabetes or syndrome X | Feb 29, 2004 | Abandoned |
Array
(
[id] => 5149454
[patent_doc_number] => 20070049514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Resonance modulator for diagnosis and therapy'
[patent_app_type] => utility
[patent_app_number] => 10/547223
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 18356
[patent_no_of_claims] => 94
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20070049514.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547223
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547223 | Resonance modulator for diagnosis and therapy | Feb 26, 2004 | Abandoned |
Array
(
[id] => 7345205
[patent_doc_number] => 20040247552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Cosmetic composition comprising at least one polymer particle dispersed in at least one liquid fatty phase and at least one ester of at least acid and at least one polyol ester'
[patent_app_type] => new
[patent_app_number] => 10/784948
[patent_app_country] => US
[patent_app_date] => 2004-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14282
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20040247552.pdf
[firstpage_image] =>[orig_patent_app_number] => 10784948
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/784948 | Cosmetic composition comprising at least one polymer particle dispersed in at least one liquid fatty phase and at least one ester of at least acid and at least one polyol ester | Feb 24, 2004 | Abandoned |
Array
(
[id] => 7427943
[patent_doc_number] => 20040229934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Method of reducing type 2 diabetes in high risk patients'
[patent_app_type] => new
[patent_app_number] => 10/783615
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3587
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229934.pdf
[firstpage_image] =>[orig_patent_app_number] => 10783615
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/783615 | Method of reducing type 2 diabetes in high risk patients | Feb 19, 2004 | Abandoned |
Array
(
[id] => 123161
[patent_doc_number] => 07705016
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-27
[patent_title] => 'Regulation of food intake by modulation of long-chain fatty acyl-CoA levels in the hypothalamus'
[patent_app_type] => utility
[patent_app_number] => 10/545056
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21445
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/705/07705016.pdf
[firstpage_image] =>[orig_patent_app_number] => 10545056
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/545056 | Regulation of food intake by modulation of long-chain fatty acyl-CoA levels in the hypothalamus | Feb 11, 2004 | Issued |
Array
(
[id] => 4543642
[patent_doc_number] => 07959946
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-14
[patent_title] => 'Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative'
[patent_app_type] => utility
[patent_app_number] => 10/777542
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8342
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 308
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/959/07959946.pdf
[firstpage_image] =>[orig_patent_app_number] => 10777542
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/777542 | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative | Feb 11, 2004 | Issued |
Array
(
[id] => 7034303
[patent_doc_number] => 20050032813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria'
[patent_app_type] => utility
[patent_app_number] => 10/767705
[patent_app_country] => US
[patent_app_date] => 2004-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3671
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032813.pdf
[firstpage_image] =>[orig_patent_app_number] => 10767705
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/767705 | Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria | Jan 28, 2004 | Abandoned |
Array
(
[id] => 7004665
[patent_doc_number] => 20050169978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Wet-micro grinding'
[patent_app_type] => utility
[patent_app_number] => 10/769118
[patent_app_country] => US
[patent_app_date] => 2004-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2971
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20050169978.pdf
[firstpage_image] =>[orig_patent_app_number] => 10769118
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/769118 | Wet-micro grinding | Jan 28, 2004 | Abandoned |
Array
(
[id] => 7462596
[patent_doc_number] => 20040166162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid'
[patent_app_type] => new
[patent_app_number] => 10/761805
[patent_app_country] => US
[patent_app_date] => 2004-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8342
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20040166162.pdf
[firstpage_image] =>[orig_patent_app_number] => 10761805
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/761805 | Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid | Jan 20, 2004 | Abandoned |
Array
(
[id] => 7425040
[patent_doc_number] => 20040208922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Method for loading lipid like vesicles with drugs or other chemicals'
[patent_app_type] => new
[patent_app_number] => 10/759222
[patent_app_country] => US
[patent_app_date] => 2004-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6813
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20040208922.pdf
[firstpage_image] =>[orig_patent_app_number] => 10759222
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/759222 | Method for loading lipid like vesicles with drugs or other chemicals | Jan 19, 2004 | Abandoned |
Array
(
[id] => 7419327
[patent_doc_number] => 20040228888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Cosmetic or dermatological formulations of improved pearlescence'
[patent_app_type] => new
[patent_app_number] => 10/759254
[patent_app_country] => US
[patent_app_date] => 2004-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15415
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20040228888.pdf
[firstpage_image] =>[orig_patent_app_number] => 10759254
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/759254 | Cosmetic or dermatological formulations of improved pearlescence | Jan 19, 2004 | Issued |
Array
(
[id] => 5620041
[patent_doc_number] => 20060189575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Use of sphingolipids for reducing plasma cholesterol and triacylglycerol levels'
[patent_app_type] => utility
[patent_app_number] => 10/542845
[patent_app_country] => US
[patent_app_date] => 2004-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8713
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20060189575.pdf
[firstpage_image] =>[orig_patent_app_number] => 10542845
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/542845 | Use of sphingolipids for reducing high plasma cholesterol and high triacylglycerol levels | Jan 19, 2004 | Issued |